UAE Biotechnology And Pharmaceutical Services Outsourcing Market Size & Outlook
UAE biotechnology and pharmaceutical services outsourcing market, 2018-2030 (US$M)
Related Markets
UAE biotechnology and pharmaceutical services outsourcing market highlights
- The UAE biotechnology and pharmaceutical services outsourcing market generated a revenue of USD 218.1 million in 2023 and is expected to reach USD 293.0 million by 2030.
- The UAE market is expected to grow at a CAGR of 4.3% from 2024 to 2030.
- In terms of segment, consulting was the largest revenue generating services in 2023.
- Regulatory Affairs is the most lucrative services segment registering the fastest growth during the forecast period.
Biotechnology and pharmaceutical services outsourcing market data book summary
| Market revenue in 2023 | USD 218.1 million |
| Market revenue in 2030 | USD 293.0 million |
| Growth rate | 4.3% (CAGR from 2023 to 2030) |
| Largest segment | Consulting |
| Fastest growing segment | Regulatory Affairs |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Consulting, Regulatory Affairs, Product Design & Development, Auditing and Assessment, Product Maintenance, Training & Education |
| Key market players worldwide | PAREXEL, IQVIA Holdings Inc, Heidelberg Materials AG, Labcorp Holdings Inc, Charles River Laboratories International Inc, Icon PLC, Syneos Health, Lonza Group Ltd, Catalent Inc, Samsung BioLogics |
Other key industry trends
- In terms of revenue, UAE accounted for 0.5% of the global biotechnology and pharmaceutical services outsourcing market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Middle East & Africa, Saudi Arabia biotechnology and pharmaceutical services outsourcing market is projected to lead the regional market in terms of revenue in 2030.
- UAE is the fastest growing regional market in Middle East & Africa and is projected to reach USD 293.0 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Biotechnology And Pharmaceutical Services Outsourcing Market Scope
Biotechnology And Pharmaceutical Services Outsourcing Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
UAE biotechnology and pharmaceutical services outsourcing market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to biotechnology and pharmaceutical services outsourcing market will help companies and investors design strategic landscapes.
Consulting was the largest segment with a revenue share of 34.98% in 2023. Horizon Databook has segmented the UAE biotechnology and pharmaceutical services outsourcing market based on consulting, regulatory affairs, product design & development, auditing and assessment, product maintenance, training & education covering the revenue growth of each sub-segment from 2018 to 2030.
In UAE, the biotechnology & pharmaceutical services outsourcing market offers a unique opportunity for international and local biotechnology and pharmaceutical companies.
The market is expected to witness continuous growth due to the rising prevalence of several chronic diseases, growing investments in complex biologic molecules development, a supportive regulatory environment, entry of new players, and growing year-on-year investments of foreign biotechnology & pharmaceutical companies & outsourcing services.
Moreover, the market is fueled by the primary emphasis of domestic players on regulatory activities focused on the expansion of pharmaceutical production capacities and geographical presence through various strategies. Such factors support the production of pharmaceutical products in the country.
Reasons to subscribe to UAE biotechnology and pharmaceutical services outsourcing market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of UAE biotechnology and pharmaceutical services outsourcing market databook
-
Our clientele includes a mix of biotechnology and pharmaceutical services outsourcing market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the UAE biotechnology and pharmaceutical services outsourcing market , including forecasts for subscribers. This country databook contains high-level insights into UAE biotechnology and pharmaceutical services outsourcing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
UAE biotechnology and pharmaceutical services outsourcing market size, by services, 2018-2030 (US$M)
UAE Biotechnology And Pharmaceutical Services Outsourcing Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
